Did you know that breast cancer is currently the most diagnosed cancer in women in the US? It is also the second leading cause of cancer death in American women. Luckily, there is some good news. According to the American Cancer Society, breast cancer deaths are declining, thanks to proactivity in screening, early detection, and high-quality treatment. Breast cancer risk assessment can play a large role in a successful breast screening program.
Precision screening is increasingly becoming the popular approach to breast cancer screening with the aim of strict follow-up in high-risk women. Breast cancer risk models within MagView helps you categorize a woman’s risk of breast cancer using their personal reproductive and medical history.
Certain risk assessment models check factors such as BRCA1 or BRCA2 inherited gene mutation linked to a high risk of breast cancer. Other key risk factors include:
The more positive answers given, the more likely a person is at high risk of breast cancer. The risk models built into MagView assess the likelihood of developing breast cancer over the next five years and up to a lifetime.
MagView allows you to use several risk assessment models to assess your patients. The Tyrer-Cuzick v8.0 (IBIS) is one of the most reliable breast cancer risk assessment tools you can use for a professional assessment. The tool checks various family factors, reproductive history, and overall medical history to estimate a patient’s breast cancer risk. Other risk models include NCI, Claus, NCCN, BCSC, HERA, and many more.
Need a robust risk program for breast cancer screening? MagView has a solid solution for you. Our breast cancer risk assessment software allows you to receive patients’ assessment scores, communicate with your patient, follow up and manage the entire screening process smoothly.
Contact us to learn more about our programs and how we can help streamline your operations.